Exelixis initiates phase 3 trial of Cabozantinib/Atezolizumab combo in prostate cancer

Exelixis initiates phase 3 trial of Cabozantinib/Atezolizumab combo in prostate cancer. (Credit: PublicDomainPictures from Pixabay)